HighMark Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $817K | Buy |
26,100
+20,000
| +328% | +$626K | 0.4% | 34 |
|
|
2025
Q1 | $205K | Hold |
6,100
| – | – | 0.12% | 55 |
|
|
2024
Q4 | $239K | Buy |
6,100
+1,100
| +22% | +$43.1K | 0.14% | 47 |
|
|
2024
Q3 | $197K | Hold |
5,000
| – | – | 0.11% | 65 |
|
|
2024
Q2 | $195K | Hold |
5,000
| – | – | 0.12% | 64 |
|
|
2024
Q1 | $215K | Buy |
+5,000
| New | +$215K | 0.13% | 57 |
|